2022 ALERT HAN Messages

Table of Contents

• ADPH ALERT Messages
• CDC HAN Messages

View the ADPH HAN Alert Archives.

ADPH ALERT Messages

12/12/2022
Medicaid Removes Requirements to Submit Illicit Drug and Alcohol Test Results with Prior Authorization for Hepatitis C Antiviral Treatment

12/2/2022
Bebtelovimab Not Authorized in U.S. for Current SAR-CoV-2 Subvariants

11/28/2022
CDC Releases Information on a Rise in Cholera Cases Worldwide 

11/21/2022
CDC Updates Guidance for Clinicians Treating Patients at Risk for Severe Monkeypox Disease

11/14/2022
The Alabama Department of Public Health Reminds Health Providers to Report Influenza Deaths to Public Health and Encourages Participation in Respiratory Surveillance Networks 

11/10/22
Ebola Virus Disease (Sudan ebolavirus) Outbreak Information for Alabama Healthcare Professionals

11/03/22
Outbreak of Ebola Virus Disease (EVD) in Central Uganda- Be Prepared to Identify, Isolate, and Inform

10/04/22
Monkeypox Update

09/28/22
ADPH Health Advisory-Interim Infection Prevention and Control Recommendations for Healthcare Personnel During the Coronavirus Disease 2019 (COVID-19) Pandemic

09/28/22
Testing for Monkeypox (MPX) in Jefferson County

09/12/22
Joint Effort of ADPH and AMA to Stop the Rise of Congenital Syphilis in Alabama

08/31/22
Monkeypox Update

08/15/22
Bebtelovimab Commercial Transition

08/09/22
Highest Recorded Congenital Syphilis in Alabama: Let's Stop It!

08/02/22
Monkeypox Situation Update

07/18/22
Testing for Monkeypox (MPX) in Jefferson County

07/08/22
Guidance for Monkeypox Test Submission

07/05/22
Precautions for COVID-19 Therapeutics

06/18/22
CDC and ADPH Health Advisory on Monkeypox Virus Infections in the United States and Other Non-endemic Countries – 2022

05/26/22
UPDATED with additional Epidemiologic, Clinical, and Exclusion Criteria: CDC and ADPH Health Advisory on Monkeypox Virus Infections in the United States and Other Non-endemic Countries - 2022

05/24/22
COVID-19 Rebound after Paxlovid Treatment

05/23/22
CDC and ADPH Health Advisory on Monkeypox Virus Infections in the United States and Other Non-endemic Countries - 2022

05/06/22
Temporary Shortage of Contrast Media

05/02/22
Modifications to Reporting Requirements for Negative SARS-CoV-2 Antigen Results

04/28/22
Updated Information on Availability and Use of Treatments for Outpatients with Mild to Moderate COVID-19 Who are at Increased Risk for Severe Outcomes of COVID-19

04/21/22
Recommendations for Adenovirus Testing and Reporting of Children with Acute Hepatitis of Unknown Etiology Summary

04/07/22
Distribution of Sotrovimab Paused to All HHS Regions

03/17/22
Free CME Training Available-University of Alabama at Birmingham (UAB) Sanitation Health Study

02/14/22
Centers for Disease Control and Prevention (CDC) Updates COVID-19 Vaccination
Guidance

02/14/22
United States Food and Drug Administration (FDA) authorizes Eli Lilly’s COVID-19
Monoclonal Antibody Drug Bebtelovimab

02/01/22
Call to Report: Providers Encouraged to Report Certain Symptomatic Patients with
Adenovirus Infections

01/25/22
FDA Limits Use of Certain Monoclonal Antibodies to Treat COVID-19 Due to Omicron Variant

01/10/2022
Limited Therapeutic Options for Outpatient Treatment of COVID-19

01/07/2022
FDA Amends EUA for COMIRNATY/Pfizer-BioNTech and Moderna mRNA Vaccines and CDC/ACIP Endorses New Recommendations

01/03/2022
Monoclonal Antibody Update: Paused Monoclonal Antibodies for Treatment of COVID-19 Disease Available Again

CDC HAN Messages

06/14/22
Updated Case-finding Guidance: Monkeypox Outbreak—United States, 2022

05/24/22
COVID-19 Rebound after Paxlovid Treatment

05/20/22
Monkeypox Virus Infection in the United States and Other Non-endemic Countries --- 2022

05/11/22
Updated Recommendations for Adenovirus Testing and Reporting of Children with Acute Hepatitis of Unknown Etiology

04/25/22
Updated Information on Availability and Use of Treatments for Outpatients with Mild to Moderate COVID-19 Who are at Increased Risk for Severe Outcomes of COVID-19

04/21/22
Recommendations for Adenovirus Testing and Reporting of Children with Acute Hepatitis of Unknown Etiology